↓ Skip to main content

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

Overview of attention for article published in Trials, March 2007
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy
Published in
Trials, March 2007
DOI 10.1186/1745-6215-8-8
Pubmed ID
Authors

Vera Hirsh, John Glaspy, Paul Mainwaring, Christian Manegold, Rodryg Ramlau, Joseph E Eid

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 4%
Unknown 27 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 29%
Student > Ph. D. Student 6 21%
Researcher 3 11%
Professor > Associate Professor 2 7%
Lecturer > Senior Lecturer 1 4%
Other 3 11%
Unknown 5 18%
Readers by discipline Count As %
Medicine and Dentistry 11 39%
Nursing and Health Professions 5 18%
Agricultural and Biological Sciences 2 7%
Mathematics 1 4%
Psychology 1 4%
Other 3 11%
Unknown 5 18%